Tumor-infiltrating OT1s across treatment groups could be divided into Slamf6+CD39– Texprog and Slamf6–CD39+ cells encompassing Texint, Texeff, and terminally differentiated Texterm CD8+ subsets (Figure 3D). The gene discussed is SLAMF6; the disease is neoplasm.